Innocoll, Inc.
Innocoll Agrees the Sale of its CollaRx GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Published in Drug Law Weekly, September 18th, 2007
Innocoll, Inc. announced that it has agreed the sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European sales and marketing infrastructure to EUSA Pharma Inc., a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care. The transaction provides EUSA with rights to Innocoll's GENTAMICIN SURGICAL IMPLANT, a biodegradable leave-behind surgical implant for the treatment and prevention of surgical site infections, for all worldwide markets except the US. Similar rights to Innocoll's two late stage development products, CollaRx GENTAMICIN TOPICAL for the treatment and prevention of diabetic foot infections and CollaRx BUPIVACAINE IMPLANT for the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-09-18)
More Articles from Drug Law Weekly
- Biotechnology Business
DaVita Receives Civil Complaint - Drug Abuse
Denton County, Texas to Implement and Fund Hythiam's First County Level PROMETA Treatment Program for Substance Dependence Among Probationees - Epidemiology
Teen Binge Drinkers Risk Alcoholism and Social Exclusion as Adults - Fibrosis
Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress - Health Maintenance Organizations
New Jersey High Court Denies Nationwide Class-Action Status to Insurance Companies Seeking VIOXX Reimbursements - Health Policy
Research conducted at University of York, Center for Health Economics has updated our knowledge about health policy - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
